The pheochromocytoma PC12 cell line that develops neuronal characteristics
of sympathetic cells after treatment with nerve growth factor (NGF) represe
nts a well-established cellular model system for studying NGF signalling. I
nteresting information on the different mechanistic pathways of NGF can be
obtained by adopting the pharmacological approach of inhibiting P2 receptor
s, expressed in naive PC12 cells and recognised as important biological med
iators of neurotransmitters and growth factors. We show here that Basilen B
lue, an antagonist of P2 receptor, reversibly prevents NGF-dependent neurit
e outgrowth with an IC50 in the 5-10 mu M range. Suramin, oxidised-ATP and
diisothiocyanatostilbene-disulfonic acid, differently from other purinocept
or ligands, are also effective in this regard. NGF-dependent regeneration a
nd stability of neurites, selected NGF-dependent extracellular and intracel
lular protein phosphorylations, binding of [H-3] ATP to PC12 cell membranes
are also modulated by Basilen Blue. On the contrary, cell adhesion, cellul
ar duplication, Sr-nucleotidase activity, NGF-induced tyrosine autophosphor
ylation of TrkA receptors are not affected. NGF furthermore directly modula
tes the extracellular release of ATP and especially the levels of P2X(2) re
ceptor protein in PC12 cells. In addition, extracellular ATP improves the n
euritogenic effect of sub-optimal concentrations of NGF.
Our study identifies P2 receptor ligands, particularly Basilen Blue, as use
ful tools to dissect different NGF-evoked functions, suggesting a mechanist
ic role for P2 receptors in the signalling pathways of NGF. (C) 2000 Elsevi
er Science Ltd. All rights reserved.